Evidence map›Paper›PMID 34563151›Full record

ArticleBMC public health2021

Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control.

Clotilde El Guerche-Séblain, Thierry Rigoine De Fougerolles, Kim Sampson, Lance Jennings, Paul Van Buynder, Yuelong Shu, Zamberi Sekawi, Leo Yee-Sin, Tony Walls, Olivier Vitoux and 4 more

Abstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Journal of preventive medicine and hygiene · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nurse, Give Me the News! Understanding Support for and Opposition to a COVID-19 Health Screening System.International journal of environmental research and public health · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Global respiratory virus surveillance: strengths, gaps, and way forward.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Clotilde El Guerche-SéblainGlobal Medical Evidence Generation (MEG) Lead, Influenza Sanofi Pasteur, Medical Influenza Franchise, Sanofi-Aventis (Singapore) Pte. Ltd. 38, Beach Road, #18-11, South Beach Tower, Sanofi Pasteur, Singapore, Singapore. clotilde.elguercheseblain@sanofi.com.ORCID 0000-0003-0196-4357
Thierry Rigoine De FougerollesCVA, Paris, France.
Kim SampsonAsia-Pacific Alliance for the Control of Influenza (APACI), Melbourne, Australia.
Lance JenningsUniversity of Otago, Christchurch, New Zealand.
Paul Van BuynderDepartment of Public Health, Griffith University, Griffith, Victoria, Australia.
Yuelong ShuSchool of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Zamberi SekawiChair Malaysia Influenza Working Group (MIWG), Universiti Putra, Seri Kembangan, Malaysia.
Leo Yee-SinNational Center for Infectious Diseases (NCID), Singapore, Singapore.
Tony WallsUniversity of Otago, Christchurch, New Zealand.
Olivier VitouxCVA, Paris, France.
J Kevin YinGlobal Medical Affairs, Sanofi Pasteur, Singapore, Singapore.
Ada WongPublic Affairs, Sanofi Pasteur, Singapore, Singapore.
Francois SchellevisNetherlands Institute for Health Services Research, Utrecht, The Netherlands.
Philippe VanhemsUnité d'Hygiène, Epidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Western Pacific Region (WPR) is exposed each year to seasonal influenza and is often the source of new influenza virus variants and novel pathogen emergence. National influenza surveillance systems play a critical role in detecting emerging viruses, monitoring influenza epidemics, improving public disease awareness and promoting pandemic preparedness, but vary widely across WPR countries. The aim of this study is to improve existing influenza surveillance systems by systematically comparing selected WPR influenza surveillance systems.

methodsThree national influenza surveillance systems with different levels of development (Australia, China and Malaysia) were compared and their adherence to World Health Organization (WHO) guidance was evaluated using a structured framework previously tested in several European countries consisting of seven surveillance sub-systems, 19 comparable outcomes and five evaluation criteria. Based on the results, experts from the Asia-Pacific Alliance for the Control of Influenza (APACI) issued recommendations for the improvement of existing surveillance systems.

resultsAustralia demonstrated the broadest scope of influenza surveillance followed by China and Malaysia. In Australia, surveillance tools covered all sub-systems. In China, surveillance did not cover non-medically attended respiratory events, primary care consultations, and excess mortality modelling. In Malaysia, surveillance consisted of primary care and hospital sentinel schemes. There were disparities between the countries across the 5 evaluation criteria, particularly regarding data granularity from health authorities, information on data representativeness, and data communication, especially the absence of publicly available influenza epidemiological reports in Malaysia. This dual approach describing the scope of surveillance and evaluating the adherence to WHO guidance enabled APACI experts to make a number of recommendations for each country that included but were not limited to introducing new surveillance tools, broadening the use of specific existing surveillance tools, collecting and sharing data on virus characteristics, developing immunization status registries, and improving public health communication.

conclusionsInfluenza monitoring in Australia, China, and Malaysia could benefit from the expansion of existing surveillance sentinel schemes, the broadened use of laboratory confirmation and the introduction of excess-mortality modelling. The results from the evaluation can be used as a basis to support expert recommendations and to enhance influenza surveillance capabilities.

Indexed as

Influenza, HumanOrthomyxoviridaeAustraliaChinaHumansMalaysiaComparative studyExpert recommendationsFrameworkInfluenzaSurveillance systemWestern Pacific regionWHO guideline adherence

Identifiers

PMID34563151
PMCPMC8466892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.